Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tenax Therapeutics (TENX) Equity Ratio (2016 - 2017)

Historic Equity Ratio for Tenax Therapeutics (TENX) over the last 6 years, with Q3 2017 value amounting to 0.92.

  • Tenax Therapeutics' Equity Ratio rose 1813.63% to 0.92 in Q3 2017 from the same period last year, while for Sep 2017 it was 0.92, marking a year-over-year increase of 1813.63%. This contributed to the annual value of 0.73 for FY2016, which is N/A changed from last year.
  • Per Tenax Therapeutics' latest filing, its Equity Ratio stood at 0.92 for Q3 2017, which was up 1813.63% from 0.84 recorded in Q2 2017.
  • In the past 5 years, Tenax Therapeutics' Equity Ratio registered a high of 0.92 during Q3 2017, and its lowest value of 0.56 during Q2 2013.
  • Moreover, its 4-year median value for Equity Ratio was 0.78 (2016), whereas its average is 0.51.
  • Per our database at Business Quant, Tenax Therapeutics' Equity Ratio tumbled by 56910.61% in 2013 and then skyrocketed by 1813.63% in 2017.
  • Tenax Therapeutics' Equity Ratio (Quarter) stood at 0.56 in 2013, then soared by 248.09% to 0.83 in 2015, then fell by 11.29% to 0.73 in 2016, then grew by 25.79% to 0.92 in 2017.
  • Its Equity Ratio was 0.92 in Q3 2017, compared to 0.84 in Q2 2017 and 0.74 in Q1 2017.